Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Eli Lilly (NY:LLY)

1,039.51 -23.24 (-2.19%)
Official Closing Price Updated: 7:00 PM EST, Jan 27, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Eli Lilly

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
News headline image
The Great Broadening: Why Early 2026 is Redefining the Market’s Winning Ticket
As the first month of 2026 draws to a close, the narrative that dominated Wall Street for the better part of three years—the undisputed reign of mega-cap technology—is rapidly fracturing. In its place,... 
Via MarketMinute
Topics Economy
News headline image
As Jensen Huang Preps to Visit China, How Should You Play Nvidia Stock?
Nvidia is a tech stock that has outpaced the broader markets by a significant margin over the past decade. Is NVDA still a good buy as Jensen Huang prepares to visit China? 
Via Barchart.com
Topics Artificial Intelligence Government Supply Chain
News headline image
The Biotech Renaissance: Scientific Breakthroughs and M&A Frenzy Spark a New Bull Market
The U.S. biotech sector has officially entered a new golden age. As of January 22, 2026, the industry is witnessing a "renaissance" that has effectively erased the memories of the grueling three-year... 
Via MarketMinute
Topics Artificial Intelligence ETFs Initial Public Offering
News headline image
Eli Lilly (LLY) Q2 2025 Earnings Call Transcript ↗
Eli Lilly (LLY) Q2 2025 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings
News headline image
Eli Lilly (LLY) Q3 2024 Earnings Call Transcript ↗
Eli Lilly (LLY) Q3 2024 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings
News headline image
Eli Lilly (LLY) Q4 2024 Earnings Call Transcript ↗
Eli Lilly (LLY) Q4 2024 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings
News headline image
Eli Lilly and Co&#39;s Options Frenzy: What You Need to Know ↗
 
Via Benzinga
News headline image
ELI LILLY AND COMPANY INVESTOR ALERT: Scott+Scott Attorneys at Law LLP Investigates Eli Lilly and Company’s Directors and Officers for Breach of Fiduciary Duties – LLY
From Scott+Scott Attorneys at Law LLP
Via Business Wire
News headline image
Why Eli Lilly (LLY) Stock Is Up Today
Shares of global pharmaceutical company Eli Lilly (NYSE:LLY) jumped 3.5% in the afternoon session after the U.S. Food and Drug Administration (FDA) granted a Breakthrough Therapy designation for its... 
Via StockStory
Topics Artificial Intelligence Supply Chain
News headline image
Beyond the Silicon: NVIDIA and Eli Lilly Launch $1 Billion ‘Physical AI’ Lab to Rewrite the Rules of Medicine
In a move that signals the arrival of the "Bio-Computing" era, NVIDIA (NASDAQ: NVDA) and Eli Lilly (NYSE: LLY) have officially launched a landmark $1 billion AI co-innovation lab. Announced during the... 
Via TokenRing AI
Topics Artificial Intelligence Economy Intellectual Property
News headline image
J&J Forecasts $100 Billion Milestone for 2026 as Trump Drug Pricing Deals Reshape the Pharma Landscape
NEW BRUNSWICK, N.J. — In a landmark display of resilience and strategic pivoting, Johnson & Johnson (NYSE: JNJ) reported fourth-quarter 2025 revenues of $24.56 billion on Wednesday, January 21, 2026,... 
Via MarketMinute
Topics Earnings Economy Government
News headline image
Eli Lilly Stock Report: Momentum, Earnings And Analyst Targets ↗
Eli Lilly's stock is experiencing short-term volatility due to its proximity to a 52-week high and upcoming earnings, amid strong analyst support and mixed technical indicators. 
Via Talk Markets
News headline image
Q3 Earnings Roundup: Zoetis (NYSE:ZTS) And The Rest Of The Branded Pharmaceuticals Segment
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how branded pharmaceuticals stocks fared in Q3, starting with... 
Via StockStory
Topics Artificial Intelligence Intellectual Property
News headline image
Here&#39;s How Much You Would Have Made Owning Eli Lilly and Co Stock In The Last 5 Years ↗
 
Via Benzinga
News headline image
What Happened to Viking Therapeutics in 2025, And Is it a Buy for 2026? ↗
Despite a challenging year, the company has a lot to look forward to in the coming years. 
Via The Motley Fool
News headline image
Is Oral Wegovy a Game Changer for Novo Nordisk? ↗
The past couple of years have been challenging for the company. But this could be the beginning of a new chapter. 
Via The Motley Fool
News headline image
AstraZeneca Signals End of an Era: Formal Move to NYSE Triggers Major Index Rebalancing
LONDON — January 20, 2026 — In a milestone moment for global capital markets, pharmaceutical giant AstraZeneca (NYSE: AZN) has officially filed its formal notice of voluntary withdrawal from the Nasdaq... 
Via MarketMinute
Topics Regulatory Compliance
News headline image
3 Biotech Stocks That Look Like “Sure-Fire” Winners in 2026 ↗
Via MarketBeat
News headline image
Prediction: This Healthcare Stock Could Soar by 72% in 2026 ↗
And the share price appreciation could happen pretty soon. 
Via The Motley Fool
News headline image
Down 55%, Should You Buy the Dip on Pfizer? ↗
Pfizer's stock has started to turn higher, but it is still down massively; is now the time to jump aboard? 
Via The Motley Fool
Topics Intellectual Property
News headline image
Ozempic, Mounjaro, Wegovy, or Zepbound? This ETF Holds Them All ↗
Via MarketBeat
Topics ETFs
News headline image
Silicon Meets Science: NVIDIA and Eli Lilly Launch $1 Billion AI Lab to Engineer the Future of Medicine
In a move that signals a paradigm shift for the pharmaceutical industry, NVIDIA (NASDAQ: NVDA) and Eli Lilly and Company (NYSE: LLY) have announced the launch of a $1 billion joint AI co-innovation... 
Via TokenRing AI
Topics Artificial Intelligence
News headline image
The Best Healthcare Stocks to Buy With $5,000 in 2026 and Hold Forever ↗
All three of these healthcare giants are leaders in their niches. 
Via The Motley Fool
Topics Artificial Intelligence
News headline image
The Trillion-Dollar Pharmacopeia: Eli Lilly’s (LLY) Dominance in the Age of Incretins
As of January 19, 2026, the pharmaceutical landscape is being redefined by a single name: Eli Lilly and Company (NYSE: LLY). Once a steady, century-old stalwart known for its dominance in the insulin... 
Via Finterra
Topics Economy
News headline image
The New Era of Johnson & Johnson: A 2026 Deep-Dive Research Feature
As of January 19, 2026, Johnson & Johnson (NYSE: JNJ) stands as a radically different enterprise than the one most investors recognized just three years ago. Following the successful spin-off of its... 
Via Finterra
Topics Artificial Intelligence Bankruptcy Economy
News headline image
Prediction: 2026 Will Be the Year of Eli Lilly ↗
A catalyst lies just ahead. 
Via The Motley Fool
News headline image
Should Investors Worry About Regional Banks After One Firm Dumped 1.8 Million Western Alliance Shares? ↗
Western Alliance Bancorporation delivers commercial and consumer banking solutions across key western U.S. markets. 
Via The Motley Fool
This Is My No. 1 Recommended Vanguard ETF to Buy in 2026 ↗
The stars could be aligning for healthcare stocks this year. This Vanguard ETF is a great way to play it. 
Via The Motley Fool
Topics ETFs Economy
News headline image
Could Acquiring Ventyx Biosciences Send Eli Lilly Stock Soaring in 2026? ↗
The pharmaceutical leader has plenty of cash and is using it effectively. 
Via The Motley Fool
Topics Intellectual Property
News headline image
Why a $6 Million Allocation to Short-Dated Credit Stands Out Right Now ↗
The Invesco BulletShares 2026 Corporate Bond ETF targets investment grade U.S. corporate bonds maturing in 2026 with a defined maturity profile. 
Via The Motley Fool
Topics Bonds ETFs Regulatory Compliance
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.